Liver
Tech
TUDCA 250 mg

symbolsMadeincanada-icon

The US Food and Drug Administration approved hydrophilic bile acid for the treatment of certain cholestatic liver diseases.

USD $ 58.58

Quantity

Product Description

Ingrédients médicinaux per Capsule Sodium TUDCA………………………………..250 mg
(Acide tauroursodéoxycholique de sodium)

Ingrédients non médicinaux
Cellulose, stéarate de magnésium (calibre végétal), silice, gélatine (capsules)

Usage recommandé: Prendre 1 à 2 capsules par jour. Ne pas dépasser 4 capsules par jour.

Avis

Il n’y a pas encore d’avis.

Be the first to review “TUDCA 250 mg”

INFORMATION COMPLEMENTAIRE

(FRENCH TRANSLATION NEEDED) The US Food and Drug Administration approved hydrophilic bile acid for the treatment of certain cholestatic liver diseases. It inhibits oxygen radical production, reducing endoplasmic reticulum (ER) stress and stabilizing the unfolded protein response (UPR). That ER stress contributes to insulin resistance and treatment with Tauroursodeoxycholic acid (TUDCA), a hydrophilic bile acid derivative that acts as a chemical chaperone to enhance protein folding, ameliorating ER stress and increasing insulin sensitivity.1 References http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911053/